About Enhancer

Enhancer ID: E_02_0726
Species: human
Position : chr3:181709320-181711320
Biosample name:
Experiment class : High+Lowthroughput
Enhancer type: Enhancer
Disease: --
Pubmed ID:  33060580
Enhancer experiment: ChIP-seq,RNA-seq,ATAC-seq,Immunoblotting
Enhancer experiment description: We further show that DOT1L inhibition affects accessibility of SOX2-bound enhancers and impairs SOX2 binding in neural pro_x005f_x0002_genitors.

About Target gene

Target gene : SOX2(ANOP3,MCOPS3)
Strong evidence: qRT-PCR,qPCR,ChIP,3C
Less strong evidence: RNA-Seq
Target gene experiment description: We further show that DOT1L inhibition affects accessibility of SOX2-bound enhancers and impairs SOX2 binding in neural pro_x005f_x0002_genitors.

About TF

TF name : --
TF experiment: ChIP-seq,RNA-seq,ATAC-seq,Immunoblotting
TF experiment description: We further show that DOT1L inhibition affects accessibility of SOX2-bound enhancers and impairs SOX2 binding in neural pro_x005f_x0002_genitors.

About Function

Enhancer function : We further show that DOT1L inhibition affects accessibility of SOX2-bound enhancers and impairs SOX2 binding in neural pro_x005f_x0002_genitors.
Enhancer function experiment: Immunohistochemical staining
Enhancer function
experiment description:
We further show that DOT1L inhibition affects accessibility of SOX2-bound enhancers and impairs SOX2 binding in neural pro_x005f_x0002_genitors.

About SNP

SNP ID: --

Upstream Pathway Annotation of TF

GeneName Pathway Name Source Gene Number

Enhancer associated network

The number on yellow line represents the distance between enhancer and target gene

Expression of target genes for the enhancer


Enhancer associated SNPs